Givaudan stock: analysis & valuation

GIVN.SWSpecialty ChemicalsSwitzerlandData as of Nov 15, 2026
Metrics analysis · Specialty Chemicals

Givaudan GIVN.SW

Price 4,090.00 CHF −0.02%Market cap 37.8 bn CHF52 weeks 2,566.00 – 4,137.00
Forward P/E
30.3x
Industry 15.7x
EV/EBITDA
26.8x
Industry 11.9x
Revenue growth
-1.7%
Industry 7.9%
Operating margin
17.9%
Industry 12.2%
Return on equity
22.3%
Industry 8.7%
Free cash flow yield
1.6%
Industry 3.5%

What does Givaudan do?

Givaudan is a Swiss manufacturer of fragrances, flavors and active ingredients, supplying mainly the consumer goods industry. The business is divided into two divisions: Fragrance & Beauty and Taste & Wellbeing. The former develops perfume oils for fine fragrance, personal care, and household and fabric care products, as well as fragrance ingredients and cosmetic active ingredients.

Taste & Wellbeing supplies flavors, taste solutions and functional ingredients for beverages, dairy products, snacks, savory products, baked goods and confectionery. The company earns money by developing customer-specific formulations and selling the products in long-term supply relationships to food, beverage and consumer goods manufacturers. Givaudan is among the world's leading providers in an industry shaped by a few large competitors. Competitive advantages arise from research and development, proprietary ingredients, customer proximity, global presence and high switching costs, as formulations are firmly embedded in customers' products.

Score profile

Quality8.7
Valuation0.8
Growth0.8
Financial strength1.9
Momentum9.9

Rank vs. Specialty Chemicals (43 companies). 10 = top of the group, 5 = middle. Calculated from the metrics below, without AI.

Metrics compared with the industry

On profitability and quality, Givaudan ranks among the best in the group Specialty Chemicals (8.7/10). On growth, the company ranks in the bottom fifth in the group Specialty Chemicals (0.8/10). On valuation (higher = cheaper), the stock ranks in the bottom fifth in the group Specialty Chemicals (0.8/10). On financial strength, Givaudan ranks in the bottom fifth in the group Specialty Chemicals (1.9/10).

MetricStockGroup medianRanking
Forward P/E30.3x15.7xbetter than 13 %
Trailing P/E39.8x29.6xbetter than 26 %
PEG ratio4.7x2.0xbetter than 13 %
EV/EBITDA26.8x11.9xbetter than 1 %
Price/sales5.1x1.6xbetter than 6 %
Price/book8.6x2.3xbetter than 10 %
Revenue growth-1.7%7.9%better than 6 %
Earnings growth-20.0%0.0%better than 11 %
Gross margin43.7%31.7%better than 85 %
Operating margin17.9%12.2%better than 83 %
Net margin12.9%5.3%better than 90 %
Return on equity22.3%8.7%better than 90 %
Debt/equity110.8%68.5%better than 16 %
Current ratio1.3x1.8xbetter than 15 %
Free cash flow yield1.6%3.5%better than 24 %
Dividend yield1.8%1.8%–
Payout ratio70.1%48.8%–
Beta0.640.86–

Valuation: what is Givaudan worth?

Two valuation approaches – a discounted cash flow model and a valuation at the industry’s median multiples – give Givaudan a model range of 2,115.10 CHF to 2,115.10 CHF per share.

Price 4,090.00 CHF
Analysts 3,732.92 CHF
Fair value range 2,115.10 CHF – 2,115.10 CHFMidpoint 2,115.10 CHF (−48.3% vs. price)

18 analysts, average rating “Hold”, average price target 3,732.92 CHF (−8.7%).

The full DCF matrix, the reverse DCF (what growth the price implies) and scenarios are part of the Pro analysis.

What the business depends on

  • Demand from consumer goods and food manufacturers for fragrances and flavors determines volume in the core business.
  • Innovation, new formulations and customer project wins secure market share and support pricing.
  • Raw material and energy costs, and their pass-through to customers, significantly influence profitability.

Risks

  • Volatile prices and availability of natural and petrochemical raw materials can weigh on margins if costs are not passed on.
  • Large customers hold bargaining power, and weak consumer demand or customer destocking dampens orders.
  • Stricter regulation on ingredients, food safety and sustainability, as well as currency fluctuations, can impair costs and earnings.

What to look for with Givaudan

The operating margin (EBITDA margin) shows whether Givaudan can pass on raw material costs and retain its pricing power and efficiency in the high-margin specialty business.

Full AI analysis of Givaudan

The AI evaluates all the numbers above and turns them into an assessment with a score, strengths and weaknesses, a fair value range and risks – from €1.99; Plus (€4.99) adds business model, moat and scenarios, Pro (€9.99) also peer comparison and reverse DCF. See an example.

Analyze a stock

Results in minutes
1 Choose a stock
2 Choose the depth

See what you get first: Example Compact (Apple) PDF Plus example (Microsoft) PDF Example Pro (NVIDIA) PDF

3 Delivery
Secure payment via Stripe Report by email + PDF No subscription

Frequently asked questions about Givaudan stock

What is the P/E ratio of Givaudan stock?

Based on expected earnings, Givaudan trades at a P/E of 30.3x, compared with a median of 15.7x for the peer group Specialty Chemicals. Based on the earnings of the last twelve months it is 39.8x. (data as of Nov 15, 2026)

Does Givaudan pay a dividend?

Yes. The dividend yield is currently 1.8%, with a payout ratio of 70.1% of earnings.

Is Givaudan stock undervalued?

Measured by valuation metrics (P/E, EV/EBITDA, price/sales, PEG), Givaudan is currently valued more expensive than most companies in the group Specialty Chemicals (valuation score 0.8 out of 10). Our model calculations (DCF and industry multiples) give a range of 2,115.10 CHF to 2,115.10 CHF per share at a price of 4,090.00 CHF. This is a model calculation, not an investment recommendation.

What do analysts say about Givaudan stock?

18 analysts have an average price target of 3,732.92 CHF (−8.7% vs. the current price); the average rating is “Hold”. Analyst targets are opinions and change frequently.

Comparable stocks

All information without guarantee. Metrics from public market data, updated daily; company profile written editorially with the help of AI. Not investment advice and not a solicitation to buy or sell securities.